Emerging Infectious Diseases (Sep 2014)

Confirmed Bacillus anthracis Infection among Persons Who Inject Drugs, Scotland, 2009–2010

  • Malcolm Booth,
  • Lindsay Donaldson,
  • Xizhong Cui,
  • Junfeng Sun,
  • Stephen Cole,
  • Susan Dailsey,
  • Andrew Hart,
  • Neil Johns,
  • Paul McConnell,
  • Tina McLennan,
  • Benjamin Parcell,
  • Henry Robb,
  • Benjamin Shippey,
  • Malcolm Sim,
  • Charles Wallis,
  • Peter Q. Eichacker

DOI
https://doi.org/10.3201/eid2009.131481
Journal volume & issue
Vol. 20, no. 9
pp. 1452 – 1463

Abstract

Read online

In Scotland, the 2009 outbreak of Bacillus anthracis infection among persons who inject drugs resulted in a 28% death rate. To compare nonsurvivors and survivors, we obtained data on 11 nonsurvivors and 16 survivors. Time from B. anthracis exposure to symptoms or hospitalization and skin and limb findings at presentation did not differ between nonsurvivors and survivors. Proportionately more nonsurvivors had histories of excessive alcohol use (p = 0.05) and required vasopressors and/or mechanical ventilation (p<0.01 for each individually). Nonsurvivors also had higher sequential organ failure assessment scores (mean + SEM) (7.3 + 0.9 vs. 1.2 + 0.4, p<0.0001). Antibacterial drug administration, surgery, and anthrax polyclonal immune globulin treatments did not differ between nonsurvivors and survivors. Of the 14 patients who required vasopressors during hospitalization, 11 died. Sequential organ failure assessment score or vasopressor requirement during hospitalization might identify patients with injectional anthrax for whom limited adjunctive therapies might be beneficial.

Keywords